EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 27 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-10-20: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-20: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-20: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-20: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-10-20 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,131 0 owned after | $3.43 exercise price | 2014-10-20 | |
| 2014-10-20 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,772 0 owned after | $8.52 exercise price | 2014-10-20 | |
| 2014-10-20 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,257 0 owned after | $8.52 exercise price | 2014-10-20 | |
| 2014-10-20 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,608 0 owned after | $10.18 exercise price | 2014-10-20 | |
| 2014-10-20 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 450,000 owned after | $2.88 exercise price | 2014-10-20 | |
| 2014-10-20 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,000 375,000 owned after | $2.88 exercise price | 2014-10-20 | |
| 2014-10-20 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −82,500 1,002,500 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-20 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −80,000 922,500 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-20 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −133,334 2,100,000 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-20 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −135,000 1,965,000 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-17 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,232 0 owned after | $3.00 exercise price | 2014-10-20 | |
| 2014-10-17 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $0.71 exercise price | 2014-10-20 | |
| 2014-10-17 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,536 2,131 owned after | $3.43 exercise price | 2014-10-20 | |
| 2014-10-17 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 500,000 owned after | $2.88 exercise price | 2014-10-20 | |
| 2014-10-17 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −82,500 1,085,000 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-17 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −133,333 2,233,334 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-16 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $2.24 exercise price | 2014-10-20 | |
| 2014-10-16 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $2.09 exercise price | 2014-10-20 | |
| 2014-10-16 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,768 7,232 owned after | $3.00 exercise price | 2014-10-20 | |
| 2014-10-16 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 550,000 owned after | $2.88 exercise price | 2014-10-20 | |
| 2014-10-16 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −82,500 1,167,500 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-10-16 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −133,333 2,366,667 owned after | $0.83 exercise price | 2014-10-20 | |
| 2014-07-24 | Doyle James Edward Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,477 18,477 owned after | $16.52 exercise price | 2014-07-28 | |
| 2014-02-24 | Megan William J. Officer (SVP, Finance & PFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,000 13,000 owned after | $13.96 exercise price | 2014-02-25 | |
| 2014-02-24 | LIDGARD GRAHAM PETER Officer (Sr. VP, Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,000 47,000 owned after | $13.96 exercise price | 2014-02-25 | |
| 2014-02-24 | ARORA MANEESH Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,000 63,000 owned after | $13.96 exercise price | 2014-02-25 | |
| 2014-02-24 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $13.96 exercise price | 2014-02-25 |